Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 4/20 | 0.65 |
| ▸ | CES1 | P23141 | 4/20 | 0.65 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.62 |
| ▸ | PPARG | P37231 | 7/20 | 0.62 |
| ▸ | PPARD | Q03181 | 7/20 | 0.62 |
| ▸ | PPARA | Q07869 | 7/20 | 0.62 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.62 |
| ▸ | TSHR | P16473 | 5/20 | 0.62 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | TLR2 | O60603 | 2/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.62 |
| ▸ | FABP4 | P15090 | 2/20 | 0.62 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.62 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | ESR1 | P03372 | 1/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.62 |
| ▸ | PDE4A | P27815 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL79563 | 1.00 | CES2 (0.65) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL56011 | 1.00 | CES2 (0.65) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL155222 | 1.00 | — | — | |
| SCHEMBL160220 | 1.00 | CES2 (0.65) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL4141832 | 1.00 | CES2 (0.65) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL54806 | 1.00 | CES2 (0.65) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL41461 | 1.00 | CES2 (0.65) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL276881 | 1.00 | CES2 (0.65) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL205397 | 1.00 | CES2 (0.65) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL501797 | 1.00 | CES2 (0.65) | CES2CES1GPR84PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 598 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115109014-A | Diterpenoid compounds in euphorbia pekinensis as well as extraction method and application thereof | 沈阳药科大学 | 2022-09-27 | — | — | CN | claimed |
| EP-2132283-A1 | TRIESTER-BASED LUBRICANTS AND METHODS OF MAKING SAME | Chevron U.S.A., Inc. (US) | 2009-12-16 | — | — | EP | claimed |
| US-7544645-B2 | Triester-based lubricants and methods of making same | CHEVRON U.S.A. INC. (US) | 2009-06-09 | — | — | US | claimed |
| WO-2008124294-A1 | TRIESTER-BASED LUBRICANTS AND METHODS OF MAKING SAME | CHEVRON U.S.A. INC. (US) | 2008-10-16 | — | — | WO | claimed |
| US-20080248982-A1 | TRIESTER-BASED LUBRICANTS AND METHODS OF MAKING SAME | CHEVRON U.S.A. INC. (US) | 2008-10-09 | — | — | US | claimed |
| US-4434179-A | POLYPRENYL DERIVATIVES | SANKYO COMPANY, LIMITED (JP) | 1984-02-28 | — | — | US | claimed |
| US-20240239922-A1 | PHOTOCURABLE COMPOSITION | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-07-18 | — | — | US | disclosed |
| US-12024579-B2 | Curable liquid composition, particulate filler, and compound | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-07-02 | — | — | US | disclosed |
| US-20240192593-A1 | PHOTOSENSITIVE COMPOSITION | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-06-13 | — | — | US | disclosed |
| US-20240191003-A1 | COMPOSITION AND PHOTOSENSITIVE COMPOSITION | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-06-13 | — | — | US | disclosed |
| US-11981794-B2 | Curable composition, cured product, and compound | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-05-14 | — | — | US | disclosed |
| CN-112470551-B | Sealing agent for organic electroluminescent display element | 电化株式会社 | 2024-05-14 | — | — | CN | disclosed |
| CN-117999296-A | Composition and photosensitive composition | 东京应化工业株式会社 | 2024-05-07 | — | — | CN | disclosed |
| EP-0085255-A2 | N-acyl peptide, processes for their preparation and pharmaceutical compostions thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-08-10 | — | — | EP | disclosed |
| EP-0074770-A1 | Camptothecin-1-oxide derivatives, process for preparing same, formulations comprising said derivatives and said derivatives for use in producing an anti-tumour effect | KABUSHIKI KAISHA YAKULT HONSHA (JP) | 1983-03-23 | — | — | EP | disclosed |
| EP-0074256-A1 | Camptothecin derivatives, processes for preparing same, formulations containing such derivatives and their use | KABUSHIKI KAISHA YAKULT HONSHA (JP) | 1983-03-16 | — | — | EP | disclosed |
| US-4260551-A | ALIPHATIC OR AROMATIC ESTERS, ANTIULCER AGENTS | SANKYO COMPANY LIMITED (JP) | 1981-04-07 | — | — | US | disclosed |
| US-4192953-A | TREATMENT OF PEPTIC ULCERS | SANKYO COMPANY LIMITED (JP) | 1980-03-11 | — | — | US | disclosed |
| US-4113939-A | HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1978-09-12 | — | — | US | disclosed |
| US-4059641-A | ANTIULCER | SANKYO COMPANY LIMITED (JA) | 1977-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080248982-A1 | TRIESTER-BASED LUBRICANTS AND METHODS OF MAKING SAME | ADH5, ADH1A, ELOVL5 | CES2 379/4885CES1 588/4885GPR84 453/4885 |
| US-20240192593-A1 | PHOTOSENSITIVE COMPOSITION | PPOX, ERCC1, ERCC5 | CES2 760/4885CES1 4122/4885GPR84 4369/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.